TSE:4886Pharmaceuticals
ASKA Pharmaceutical Holdings (TSE:4886) Net Margin Miss Challenges Narrative of Steady Profit Expansion
ASKA Pharmaceutical Holdings (TSE:4886) posted a net profit margin of 7.1% for the latest period, down from 9.4% a year earlier, while also recording a one-off gain of ¥1.2 billion ahead of September 2025. Over the last five years, earnings grew at an average rate of 18% annually. However, the most recent year saw a decline, and both earnings and revenue are now forecast to rise at a more modest 2.9% per year, lagging the broader Japanese market’s growth expectations. With a current...